Last edition
News about
Vieworks Showcases Innovative X-ray Imaging Solutions at WCNDT
Vieworks, a innovator in x-ray imaging solution, recently marked a significant milestone by participating in the 21st World Conference on Non-Destructive Testing (WCNDT) for the first time.
Pulsenmore Appoints Len Farris as Chief Commercial Officer
Farris will lead Pulsenmore's global commercial growth, overseeing sales, business development, and partnerships.
Formosa Laboratories Acquires Synchem to Expand in North America
Formosa Laboratories, Inc. has completed its acquisition of SynChem, Inc., a contract research laboratory located in suburban Chicago.
ASPA Organizes Global Meet at Drupa 24 for Authentication and Traceability Professionals
The Authentication Solution Providers' Association (ASPA) has made its entry into the Middle East and Africa regions with the introduction of its MEA (Middle East & Africa) Chapter.
DefiniGEN and Atelerix to Ship In Vitro Cell Models Internationally
DefiniGEN Ltd. and Atelerix Ltd. have successfully shipped in vitro liver models from the UK to a top-tier pharma customer in the US.
ConcertAI, NVIDIA to Transform Translational and Clinical Development Solutions
ConcertAI has joined hands with NVIDIA to advance a broad set of translational and clinical development solutions within the ConcertAI CARA AI platform.
Parse Biosciences Unveils Trailmaker Data Analysis Platform
Parse Biosciences has introduced Trailmaker, its user-friendly cloud platform purpose-built for single cell data analysis.
Telix Completes TLX250-CDx BLA Submission for Kidney Cancer Imaging
Telix Pharmaceuticals has completed the submission of a Biologics License Application (BLA) to the United States (US) Food and Drug Administration (FDA) for its investigational radiodiagnostic PET agent.
GRIT and Quangang to Boost Localization of Interleukin-2
Shanghai Grit Biotechnology Co., Ltd. (GRIT) has forged a formal strategic partnership with Shandong Quangang Pharmaceutical Co., Ltd. (Quangang) to leverage both parties' R&D capabilities in innovative T-cell therapy.
Navigate BioPharma Services Unveils New Assay for Precise Measurement of Radioligand Therapies
Navigate BioPharma Services, Inc. has introduced a new assay for quantifying pharmacodynamic markers of radioligand therapies in tumors.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy